Company intelligence / Profile preview

Probiomed

Mexico City, CDMX, Mexicoyakubutsu.mhlw.go.jp ↗

Ownership: Private
Development stage: Other

Overview

Probiomed is a leading Mexican biopharmaceutical company with over five decades of experience in the research, development, manufacturing, and commercialization of generic pharmaceuticals and high-tech biosimilars. Its portfolio covers a broad range of therapeutic areas including autoimmune disease, cancer, metabolic disease, nephrology/renal failure among others. The company has an international footprint with exports to Latin America and beyond. In May 2022 it was acquired by Sanfer to strengthen its biotechnology platform.

Therapeutic areas: Metabolic DisordersNeurologyHematologyOncologyImmunology
Modalities: Small molecule (generics)Recombinant protein (biosimilars)Monoclonal antibody (biosimilars)Fusion protein (biosimilars)Vaccine (recombinant vaccines)
Industry: Biotech

Drug pipeline

1 asset

PBO-326

Partnerships

Sanfer Group (parent company; future technology transfer/commercial agreements expected as per acquisition announcement)

Beyond the preview

Go deeper on Probiomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probiomed.

Explore the full profile